The problem
Each year in the US, 125 million patients see a doctor for symptoms of bacterial infections 99% of which are negative.
Testing requires time off from work, expenses not covered by insurance, and the experience is invasive and uncomfortable.
Research has shown that many diseases are contracted from going to the hospital or even waiting in the physician’s waiting room.
THE RT MicroDx SOLUTION
An easy to use, saliva-based home test, that gives you PCR quality results at home and in minutes
We are changing the face of healthcare as we make diagnostic affordable and accessible by having them available over the counter
The future is now
The healthcare landscape is primed and ready for consumers to have control of their own health.
Healthcare System
Efforts to significantly reduce healthcare costs
Consumers
Need to have more control over their own health
Providers
Widespread implementation of virtual platforms
Our molecular platform allows patients to achieve PCR quality results for the price of an antigen test. More importantly, it can be done in the comfort of your home
Diagnostic testing has an access problem.
It is costly, unsustainable, and inequitable.
We Make At-Home Molecular Testing Simple
Affordable
Cost-effective, highly accurate molecular at-home solutions
Equitable
Designed with simplicity in mind, our tests can be self-administered with ease,
Quick & Efficient
Get accurate diagnostic information in minutes
Accurate
Leveraging advanced molecular technology and matching lab-quality standards.
Connected to telehealth and treatment
Seamless access to virtual care for immediate diagnosis and quick treatment
Affordable
Cost-effective, highly accurate molecular at-home solutions
Equitable
Designed with simplicity in mind, our tests can be self-administered with ease,
Quick & Efficient
Get accurate diagnostic information in minutes
Accurate
Leveraging advanced molecular technology and matching lab-quality standards.
Connected to telehealth and treatment
Seamless access to virtual care for immediate diagnosis and quick treatment
Decentralizing diagnostics by developing home tests that are equivalent to PCR lab tests
- Respiratory Viral Infections: Influenza, respiratory syncytial virus (RSV), and adenovirus
- Diagnostics for Infectious Diseases: Tuberculosis (TB), Ebola virus, and Zika virus
- Oral Pathogens: Periodontal disease and oral infections
- Foodborne Pathogens: Salmonella, E. coli, and Listeria in food samples to ensure food safety
- Environmental Testing: Microbial contamination in environmental samples, including water, soil, and air.
Recent News Articles
RT MicroDx Founder & CEO Nathalya Mamane to Present at Biotech Showcase During JPM Week
Boston, MA – January 2, 2023 – RT MicroDx, a biotech company working to develop a technology platform for affordable,
Q&A: Developing an at-home test for strep throat
Nathalya Mamane, chief executive officer and founder of RT MicroDx speaks to Med-Tech Innovation News about the development of an at-home test for strep throat.
“Simplifying Strep” with Nathalya Mamane of RT MicroDX
Nathalya Mamane of RT MicroDX discusses how she developed the idea from her biggest pain point as a parent to disrupt the diagnostic process by developing the technology for accessible home testing for strep throat and, ultimately, other common infections.